Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598936 · ClinicalTrials.gov registry record
A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients
A clinical trial, sponsored by University of California, Irvine.
- Terminated
- Registry status
- 21
- Enrollment target
NCT00598936: Clinical Trial study, sponsored by University of California, Irvine.
NCT00598936 is a clinical trial that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598936 was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a new cerebral oxygenation monitoring device is comparatively similar to the current approved devices.
Interventions
- DEVICE CDI 1000 COM and INVOS 5100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-05 |
Why NCT00598936 stopped before completion
NCT00598936 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CDI 1000 COM and INVOS 5100 is the first listed.
NCT00598936 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00598936 about?
NCT00598936 is a clinical study titled "A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients". The purpose of this study is to determine whether a new cerebral oxygenation monitoring device is comparatively similar to the current approved devices.
What is the current status of trial NCT00598936?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2007-11. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00598936?
The interventions under investigation include: CDI 1000 COM and INVOS 5100 (DEVICE).
Who is sponsoring clinical trial NCT00598936?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia